secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEXGEL, INC. (NXGL)
CIK:        0001468929
Form:       8-K
Filed at:   2023-08-14T23:59:59+00:00
Accession:  0001493152-23-028683
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NexGel Q2 revenue $1.17M (+108% YoY), net loss improved to $0.13/sh
-------------------------------------------------------------------

- Revenue $1.17M (+108% YoY), exceeding projections; contract manufacturing +174% YoY.
- Net loss improved to $687k ($0.13/sh) from $1M loss ($0.19/sh) in Q2 2022.
- Gross profit $175k (15% margin) vs $101k (18%) in prior-year quarter.
- Cash and equivalents $4.3M as of March 31, 2023; invested in inventory and capex for H2 demand.
- New JV with C.G. Laboratories, strategic relationship with Enigma Health, and new supply agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468929/000149315223028683/0001493152-23-028683-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468929/000149315223028683/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-028683

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer